Clinical outcomes of resected EGFR positive stage I-III NSCLC patients in the Midlands, UK

被引：0
|
作者：
Powell, R. L. [1 ]
Murukesh, N. [2 ]
Seeva, P. [2 ]
Solanki, A. [3 ]
Singh, A. [3 ]
Jain, A. [4 ]
Elmasry, A. R. [5 ]
Jegannathen, A. [5 ]
Irwin, A. [6 ]
Ghafoor, Q. [6 ]
O'Sullivan, B. [6 ]
Taniere, P. [7 ]
Baijal, S. [8 ]
机构：
[1] Univ Hosp Birmingham NHS Fdn Trust, Clin Haematol & Oncol Dept, Heartlands Hosp, Birmingham, W Midlands, England
[2] Worcestershire Royal Hosp, Dept Oncol, Worcester, England
[3] Royal Wolverhampton NHS Trust, New Cross Hosp, Deanesly Ctr, Wolverhampton, England
[4] New Cross Hosp, Royal Wolverhampton Hosp NHS Trust, Wolverhampton, England
[5] Univ Hosp North Midlands, Stoke On Trent, Staffs, England
[6] New Queen Elizabeth Hosp Birmingham, Oncol, Birmingham, W Midlands, England
[7] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England
[8] Heart England NHS Fdn Trust, Heartlands Hosp, Birmingham, W Midlands, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
67P
引用
收藏
页码：S731 / S732
页数：2
相关论文
共 50 条
  • [21] Dose-effect relation of heart dose and Overall Survival in stage I-III NSCLC patients
    Stam, B.
    Rossi, M.
    Belderbos, J.
    Sonke, J. J.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S256 - S256
  • [22] Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I-III Mucinous Colorectal Adenocarcinoma
    Liao, Yu-Cui
    Ying, Hou-Qun
    Huang, Ying
    Luo, Yan-Ran
    Xiong, Cui-Fen
    Nie, Ruo-Wei
    Li, Xiao-Juan
    Cheng, Xue-Xin
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 3455 - 3464
  • [23] Genetic alteration profile of EGFR-mutant resected IIB-IIIA stage NSCLC and correlation to clinical outcomes
    Deng, Qiuhua
    Qiu, Yuan
    Jia, Junmei
    Tang, Hailing
    Liu, Liping
    Huang, Liyan
    He, Dongyun
    Dong, Xiaomeng
    Yang, Haihong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 838 - +
  • [24] Osimertinib: A Review in Completely Resected, Early-Stage, EGFR Mutation-Positive NSCLC
    James E. Frampton
    Targeted Oncology, 2022, 17 : 369 - 376
  • [25] Osimertinib: A Review in Completely Resected, Early-Stage, EGFR Mutation-Positive NSCLC
    Frampton, James E.
    TARGETED ONCOLOGY, 2022, 17 (03) : 369 - 376
  • [26] Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study
    Wolfgang Schuette
    Peter Schirmacher
    Wilfried E. E. Eberhardt
    Manfred Dietel
    Ute Zirrgiebel
    Lars Muehlenhoff
    Michael Thomas
    BMC Cancer, 18
  • [27] ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I-III) non small cell lung cancer (NSCLC) patients (pts)
    Rosell, R
    de Lena, M
    Carpagnano, F
    Ramlau, R
    Gonzalez-Larriba, J
    Grodzki, T
    Le Groumellec, A
    Aubert, D
    Gasmi, J
    Douillard, J
    LUNG CANCER, 2005, 49 : S3 - S4
  • [28] Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study
    Schuette, Wolfgang
    Schirmacher, Peter
    Eberhardt, Wilfried E. E.
    Dietel, Manfred
    Zirrgiebel, Ute
    Muehlenhoff, Lars
    Thomas, Michael
    BMC CANCER, 2018, 18
  • [29] Utility of PET/CT in patients with stage I-III melanoma
    Aviles Izquierdo, J. A.
    Molina Lopez, I.
    Sobrini Morillo, P.
    Marquez Rodas, I.
    Mercader Cidoncha, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (08): : 1414 - 1417
  • [30] Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project
    Blackhall, Fiona H.
    Peters, Solange
    Bubendorf, Lukas
    Dafni, Urania
    Kerr, Keith M.
    Hager, Henrik
    Soltermann, Alex
    O'Byrne, Kenneth J.
    Dooms, Christoph
    Sejda, Aleksandra
    Hernandez-Losa, Javier
    Marchetti, Antonio
    Savic, Spasenija
    Tan, Qiang
    Thunnissen, Erik
    Speel, Ernst-Jan M.
    Cheney, Richard
    Nonaka, Daisuke
    de Jong, Jeroen
    Martorell, Miguel
    Letovanec, Igor
    Rosell, Rafael
    Stahel, Rolf A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2780 - +
12345